FAIR VALUE MEASUREMENTS |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Fair Value Disclosures [Abstract] | |
| FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS The Company's financial assets include held-to-maturity investments carried at amortized cost basis of $170,511 and $150,119, of which $105,987 and $81,816 are designated to support insurance subsidiary liabilities, as of September 30, 2026 and December 31, 2025, respectively. As of September 30, 2026 and December 31, 2025, the amortized cost basis of these financial assets is considered to approximate fair value and is derived using Level 2 inputs. The Company believes its amortized cost basis investments that were in an unrealized loss position as of September 30, 2026 and December 31, 2025 do not require an allowance for expected credit losses, nor has any event occurred through the filing date of this report that would indicate differently. The Company's financial assets also include the contracts insuring the lives of certain employees who are eligible to participate in non-qualified deferred compensation plans that are held in a rabbi trust. The cash surrender value of these contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan and are held at fair value. As of September 30, 2026 and December 31, 2025, the fair value of the investment funds was $91,160 and $74,405, respectively, which are derived using Level 2 inputs. Refer to Note 16, Deferred Compensation Plan for more information. Additionally, the Company has other investments held at historical cost basis, which are not material, for which the fair value is derived using Level 3 inputs.
|